0 (0%) | 09-27 11:13 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 21.59 | 1-year : | 25.22 |
Resists | First : | 18.48 | Second : | 21.59 |
Pivot price | 18.44 | |||
Supports | First : | 18.08 | Second : | 17.82 |
MAs | MA(5) : | 18.44 | MA(20) : | 18.44 |
MA(100) : | 17.99 ![]() |
MA(250) : | 13.12 ![]() |
|
MACD | MACD : | 0.02 ![]() |
Signal : | 0.03 ![]() |
%K %D | K(14,3) : | 92.42 | D(3) : | 92.42 |
RSI | RSI(14): 73.35 | |||
52-week | High : | 18.48 | Low : | 5.8 |
If tomorrow: | Open lower | Open higher |
High: | - | - |
Low: | - | - |
Close: | - | - |
Fri, 26 Sep 2025
Wilmar’s five subsidiaries fined IDR11.9 tril by Indonesian Supreme Court after being found guilty of corruption in 2021 - The Edge Singapore
Sun, 21 Sep 2025
Solidigm's Comeback: Sales Expected to Exceed 9 Tril. Won This Year - Businesskorea
Sun, 21 Sep 2025
Japan's farm exports up 3.7% to 1.5 tril. yen in 2024, new record - MSN
Tue, 16 Sep 2025
Tril SUTHERLAND Obituary (2025) - Taranaki Daily News - Legacy.com
Mon, 15 Sep 2025
Google Tops $3 Trillion Market Cap As Gemini Takes Top Spot In Apple Store - Investor's Business Daily
Tue, 09 Sep 2025
Samsung Biologics Secures 1.8 Tril. Won Mega Contract with U.S. Pharma Company - Businesskorea
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 105 (M) |
Shares Float | 87 (M) |
Held by Insiders | 5.4 (%) |
Held by Institutions | 81.8 (%) |
Shares Short | 2,310 (K) |
Shares Short P.Month | 2,810 (K) |
EPS | -0.5 |
EPS Est Next Qtrly | -0.96 |
EPS Est This Year | -4.14 |
EPS Est Next Year | -2.75 |
Book Value (p.s.) | 2.32 |
Profit Margin | 0 % |
Operating Margin | -118642 % |
Return on Assets (ttm) | -15.61 % |
Return on Equity (ttm) | -29.91 % |
Qtrly Rev. Growth | -91.31 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -0.49 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -38 (M) |
Levered Free Cash Flow | -19 (M) |
PE Ratio | -36.89 |
PEG Ratio | 0 |
Price to Book value | 7.91 |
Price to Sales | 45027.9 |
Price to Cash Flow | -0.01 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |